Crossmark

Gemifloxacin ameliorates acetic acid-induced ulcerative colitis via modulation of inflammatory, oxidative, and adhesive biomarkers and histopathological changes in rats

Crossref DOI link: https://doi.org/10.1007/s10735-025-10527-y

Published Online: 2025-07-31

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jaafar, Farrah Rasool

Attarbashee, Rana Khairi

Abu-Raghif, Ahmed Rahmah

Ridha-Salman, Hayder
License Information

Text and Data Mining valid from 2025-07-31

Version of Record valid from 2025-07-31
More Information

Article History

Received: 23 May 2025

Accepted: 30 June 2025

First Online: 31 July 2025

Declarations

:

: The authors declare no competing interests.

: The Institutional Review Board (IRB) et al.-Nahrain University’s College of Medicine gave their stamp of approval to the experimental protocol as per document number 20240908 on October 29, 2024.

Document is current

Any future updates will be listed below